Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:BioReference_Laboratories
gptkb:Prolor_Biotech |
| gptkbp:awards |
Excellence in Research
Top Employer Innovative Product Award Best_Biotech_Company |
| gptkbp:CEO |
gptkb:Phillip_Frost
|
| gptkbp:clinicalTrials |
Phase 1
Phase 2 Phase 3 investigational new drug FDA_approved |
| gptkbp:collaborations |
government agencies
academic institutions research organizations |
| gptkbp:employees |
over 1,000
|
| gptkbp:focus |
pharmaceuticals
biologics diagnostics |
| gptkbp:founded |
2007
|
| gptkbp:founder |
gptkb:Phillip_Frost
|
| gptkbp:headquarters |
gptkb:Miami,_Florida
|
| https://www.w3.org/2000/01/rdf-schema#label |
OPKO 2000
|
| gptkbp:industry |
biotechnology
|
| gptkbp:market |
gptkb:Asia
gptkb:Latin_America gptkb:United_States Europe |
| gptkbp:partnerships |
gptkb:Pfizer
gptkb:Teva_Pharmaceuticals |
| gptkbp:philanthropy |
community support
education programs healthcare_initiatives |
| gptkbp:products |
diagnostic tests
therapeutics |
| gptkbp:research |
biomarkers
clinical trials drug development genomics proteomics |
| gptkbp:revenue |
$100 million
|
| gptkbp:subsidiary |
gptkb:OPKO_Health,_Inc.
|
| gptkbp:technology |
molecular diagnostics
therapeutic proteins point-of-care testing antibody-drug conjugates biologics manufacturing |
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
www.opko.com
|